Comparative efficacy and safety of etoposide plus PEG-rhG-CSF versus etoposide plus G-CSF for haematopoietic stem cell mobilisation in patients with multiple myeloma and lymphoma - Quiz - MDSpire

Comparative efficacy and safety of etoposide plus PEG-rhG-CSF versus etoposide plus G-CSF for haematopoietic stem cell mobilisation in patients with multiple myeloma and lymphoma

  • By

  • Yiming Zhao

  • Lixia Liu

  • Wei Qian

  • Jianjun Li

  • Liang Xia

  • June 17, 2026

  • 0 min

Share

Original Source(s)

Comparative efficacy and safety of etoposide plus PEG-rhG-CSF versus etoposide plus G-CSF for haematopoietic stem cell mobilisation in patients with multiple myeloma and lymphoma

  • by Yiming Zhao, Lixia Liu, Wei Qian, Jianjun Li, Liang Xia

  • June 17, 2026

Related Content

Advancing CAR-T therapy in multiple myeloma: a critical appraisal of CARTITUDE-4 and the path toward earlier lines

Predicting CAR-T outcomes in R/R DLBCL: a multicenter real-world study of a 5-index model

Biology of p53 protein isoforms and their significance in hematological malignancies